Your browser doesn't support javascript.
loading
Transgender and Nonbinary Individuals' Perceptions Regarding Gender-Affirming Hormone Therapy and Cardiovascular Health: A Qualitative Study.
Rytz, Chantal L; Pattar, Badal S B; Mizen, Sara J; Lieb, Parker; Parsons Leigh, Jeanna; Saad, Nathalie; Dumanski, Sandra M; Beach, Lauren B; Marshall, Zack; Newbert, Amelia M; Peace, Lindsay; Ahmed, Sofia B.
Afiliação
  • Rytz CL; Libin Cardiovascular Institute, University of Calgary, Alberta, Canada. (C.L.R., B.S.B.P., S.M.D.).
  • Pattar BSB; Cumming School of Medicine, University of Calgary, Alberta, Canada. (C.L.R., B.S.B.P., P.L., S.M.D., S.B.A.).
  • Mizen SJ; Libin Cardiovascular Institute, University of Calgary, Alberta, Canada. (C.L.R., B.S.B.P., S.M.D.).
  • Lieb P; Cumming School of Medicine, University of Calgary, Alberta, Canada. (C.L.R., B.S.B.P., P.L., S.M.D., S.B.A.).
  • Parsons Leigh J; School of Health Administration, Dalhousie University, Halifax, Nova Scotia, Canada (S.J.M., J.P.L.).
  • Saad N; Cumming School of Medicine, University of Calgary, Alberta, Canada. (C.L.R., B.S.B.P., P.L., S.M.D., S.B.A.).
  • Dumanski SM; O'Brien Institute for Public Health, Cumming School of Medicine, University of Calgary, Alberta, Canada. (J.P.L.).
  • Beach LB; School of Health Administration, Dalhousie University, Halifax, Nova Scotia, Canada (S.J.M., J.P.L.).
  • Marshall Z; Department of Medicine, University of Calgary, Alberta, Canada. (N.S., S.M.D.).
  • Newbert AM; Libin Cardiovascular Institute, University of Calgary, Alberta, Canada. (C.L.R., B.S.B.P., S.M.D.).
  • Peace L; Cumming School of Medicine, University of Calgary, Alberta, Canada. (C.L.R., B.S.B.P., P.L., S.M.D., S.B.A.).
  • Ahmed SB; Department of Medicine, University of Calgary, Alberta, Canada. (N.S., S.M.D.).
Circ Cardiovasc Qual Outcomes ; : e011024, 2024 Jul 18.
Article em En | MEDLINE | ID: mdl-39022828
ABSTRACT

BACKGROUND:

Transgender and nonbinary individuals face substantial cardiovascular health uncertainties. The use of gender-affirming hormone therapy can be used to achieve one's gender-affirming goals. As self-rated health is an important predictor of health outcomes, an understanding of how this association is perceived by transgender and nonbinary individuals using gender-affirming hormone therapy is required. The objective of this research was to explore transgender and nonbinary individuals' perceptions of cardiovascular health in the context of using gender-affirming hormone therapy.

METHODS:

In this qualitative study, English-speaking transgender and nonbinary adults using gender-affirming hormone therapy for 3 months or more were recruited from across Canada using purposive and snowball sampling methods. Semistructured interviews were conducted through videoconference to explore transgender and nonbinary individuals' perceptions of the association between gender-affirming hormone therapy and cardiovascular health between May and August 2023. Data were transcribed verbatim, and transcripts were analyzed independently by 3 reviewers using thematic analysis.

RESULTS:

Twenty-one participants were interviewed (8 transgender women, 9 transgender men, and 3 nonbinary individuals; median [range] age, 27 [20-69] years; 80% White participants). Three main themes were identified cardiovascular health was not a primary concern in the decision-making process with regard to gender-affirming hormone therapy, the improved well-being associated with gender-affirming hormone therapy was felt to contribute to improved cardiovascular health, and health care provider knowledge and attitude facilitate the transition process.

CONCLUSIONS:

Gender-affirming hormone therapy in transgender and nonbinary individuals is perceived to improve cardiovascular health. Given the positive associations between care aligned with patient priorities, self-rated health, and health outcomes, these findings should be considered as part of shared decision-making and person-centered care.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article